Company: SMNR
Filing Date: 2025-09-04
Form Type: 8-K
Source: 0001213900-25-084180
Chunk: 0

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-09-04
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07. Submission of Matters to a Vote of Security Holders.

On September 3, 2025, Denali Capital Acquisition
Corp. (the “ Company”) held an extraordinary general meeting of shareholders (the “ Meeting”). The record date for
the determination of shareholders entitled to vote at the Meeting was August 12, 2025. As of the record date, there were 553,739 Class
A ordinary shares and 2,062,500 Class B ordinary shares outstanding and entitled to vote. A total of 2,461,469 shares were present in
person or by proxy, representing approximately 94.08% of the shares entitled to vote, which constituted a quorum.

At the Meeting, each of the proposals and sub-proposals
described below was approved by the Company’s shareholders. The final voting results for the proposals and sub-proposals submitted
to a vote of the Company’s shareholders at the Meeting are set forth below. No broker non-votes occurred with respect to any proposal.

Proposal 1